Whan In Pharm Co.,Ltd. (KRX:016580)

Market Cap	175.72B
Revenue (ttm)	251.73B
Net Income (ttm)	27.36B
Shares Out	15.27M
EPS (ttm)	1,792.00
PE Ratio	6.42
Forward PE	8.70
Dividend	300.00 (2.61%)
Ex-Dividend Date	Dec 27, 2024

Volume	16,977
Average Volume	12,936
Open	11,590
Previous Close	11,520
Day's Range	11,510 - 11,590
52-Week Range	11,250 - 15,900
Beta	0.20
RSI	36.38
Earnings Date	Feb 14, 2025

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceuticals products in South Korea. The company offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 582
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 016580

Financial Performance

In 2023, Whan In Pharm's revenue was 230.39 billion, an increase of 15.81% compared to the previous year's 198.93 billion. Earnings were 29.77 billion, an increase of 24.47%.